High-flow nasal cannula oxygen therapy versus conventional oxygen therapy in patients with acute respiratory failure: a systematic review and meta-analysis of randomized controlled trials.
Youfeng ZhuHaiyan YinRui ZhangJianrui WeiPublished in: BMC pulmonary medicine (2017)
HFNC therapy was similar to COT in ARF patients. The subgroup analysis showed that HFNC therapy may decrease the rate of escalation of respiratory support and the intubation rate when ARF patients were treated with HFNC for ≥24 h compared with COT. Further high-quality, large-scale studies are needed to confirm our results.
Keyphrases
- end stage renal disease
- newly diagnosed
- respiratory failure
- ejection fraction
- chronic kidney disease
- prognostic factors
- extracorporeal membrane oxygenation
- peritoneal dialysis
- cardiac arrest
- intensive care unit
- mesenchymal stem cells
- patient reported outcomes
- cell therapy
- acute respiratory distress syndrome
- double blind